The approaches hitherto used for measuring the kinetic constants Kd and Bmax of neuroreceptors in vivo all violate the steady state of the system. This com plicates the kinetic analysis as approximations must be made, introducing errors of unknown magnitude. The present study presents the theory for designing experi ments in which the steady state is preserved. It is based on maintaining a constant degree of receptor binding (oc cupancy) throughout the experiment. This is achieved by administering by prolonged intravenous infusion the non radioactive ligand one wishes to study. The fraction of receptor sites not occupied by the "cold" ligand is mea sured by using trace amounts of a radioactive ligand bind ing to the same receptor. A minimum of two studies at different occupancies must be performed. In this presen tation it is proposed to make the second study at essen tially zero receptor occupancy by administering the tracer alone. The pair of tracer studies, the one without and the other with infusion of cold ligand, allows calculation of the cold ligand's equilibrium dissociation constant Kd• In the special case when tracer and cold ligands are chemi cally identical, then Bmax can also be calculated. Two A number of radioactive ligands of neurotrans mitter receptor sites such as D" D2, 5HT 2 ' or the -y-aminobutyric acid (GAB A) A-associated central benzodiazepine receptor have been developed for in vivo studies. The aim is to assess the receptors quantitatively in vivo by measuring the binding ca- Abbreviations used: GABA, I'-aminobutyric acid; PET, posi tron emission tomography; ROI, region of interest; SPECT, sin gle photon emission tomography.
A number of radioactive ligands of neurotrans mitter receptor sites such as D" D2, 5HT 2 ' or the -y-aminobutyric acid (GAB A) A-associated central benzodiazepine receptor have been developed for in vivo studies. The aim is to assess the receptors quantitatively in vivo by measuring the binding ca-709 different modes of tracer administration can be used. If the tracer is also infused at a constant rate for a long time, then the occupancy of receptor sites by the cold ligand can be calculated by measuring the equilibrium tracer concentrations in brain and plasma. If the tracer is ad ministered as an intravenous bolus injection, then the area under the brain and plasma radioactivity curves or compartmental analysis must be used. The bolus injection approach, described in this paper for the first time, has the highest overall counting efficiency and should there fore be particularly suited for studies in man using posi tron emission tomography (PET) or single photon emis sion tomography (SPECT). Tracer infusion is the method of choice for animal experiments, as only one set of val ues are needed, those at long time, as can be obtained post vivo by counting samples of brain or by using auto radiographic techniques. The steady-state principle shows that ligands with very low Kd values, i.e., with very high affinity, are not suited for receptor quantitation. Key Words: Neuroreceptor-Steady state-Constant in fusion-Bolus injection-Radioactive tracers.
pacity B m ax and the affinity constant Kd, the latter constrant denoting the free concentration of the ligand in the brain at which half of the receptor sites are occupied. The experimental approach for such in vivo studies has in general terms consisted of a bolus injection of the tracer with high and with low specific activity, so as to obtain varying degrees of receptor occupancy, an insignificant occupancy at high specific activity and a significant one at lower specific activity. Different approaches have been used for data analysis. The pseudoequilibrium method is based on assessing the bound/free ratio at a time when this ratio is assumed to be close to its equilibrium value (Farde et aI., 1989; Pappata et aI., 1988) . With this approach the grossly variable re ceptor occupancy, i.e., the nonsteady-state, caused by the co-injected "cold" tracer creates problems. A less widely used approach consists in fitting the nonlinear differential equations pertaining to the nonsteady-state to the observed brain uptake curves (Blomquist et al., 1990; Delforges et al., 1991) .
This study analyzes experimental designs in which the steady state is maintained. The steady state principle was first proposed by Kawai et al. (1991) using continuous infusion of the tracer. Here the theory is extended so as to encompass also ex periments in which bolus injection of the tracer can be used.
THE STEADY -STATE OF THE SYSTEM
A system is in a steady state over a given period if we can inject two tracer doses by bolus input at different times and obtain the same responses, i.e., responses that only differ by the time lag between the inputs. In other words, all factors influencing the tracer response must remain constant. These factors are thus, by definition, the relevant param eters of the system. In the context of receptor stud ies, the most relevant parameter of the system is the fractional binding of the receptor, its occupancy. This parameter is influenced by the cold ligand, be cause it is infused in chemical amounts high enough to cause a significant degree of receptor occupancy. Therefore, in the context of describing the steady state, the cold ligand must be considered a system parameter that must be kept at constant concentra tion in order to maintain constant receptor occu pancy. A constant infusion of the cold ligand can conveniently be used to obtain this steady state, but peroral administration might also be employed.
The tracer can be injected in any way one wishes, as a constant infusion or as a bolus, without violat ing the system's steady state. This is so, because the tracer is injected in such small chemical amounts (with such high specific activity) that it does not cause a significant binding of free receptor sites, typically much less than 1 % even at maximal tracer concentration. For the same reason, the tracer responses are linear, i. e., proportional to the amount of tracer used.
A steady-state receptor study requires at least two tracer experiments on the same subject. In this study, the two experiments analyzed are one with out infusion of the cold ligand and one with such an infusion. It would increase the accuracy of the es timation of the cold ligand's affinity constant if more studies were performed at different rates of Vol, 12, No.5, 1992 infusion so as to obtain different degrees of receptor binding. But two studies suffice if there is only one type of receptor in a given region.
THE BASIC EQUATIONS
The law of mass action allows one to describe the equilibrium state of two different ligands T and L competing for the same receptor sites. The result is the following pair of well-known equations:
where B(T) and B(L) are the concentrations of re ceptor sites bound by the two ligands respectively; B m ax, the total concentration of receptor sites (bound and free); T and L, the free concentrations of the two ligands in the water phase; and (Kdh and (Kd)v the corresponding equilibrium constants (of ten called the dissociation constants). When one of the ligands, in this case assumed to T, is present only in trace amounts, then the de nominator in Eq. 
With G(L) known, we can calculate Kd by rearrang ing Eq. (5) as
If the radioactive tracer and the cold ligand are chemically identical so that (Kdh = (Kd)L = Kd, then Bma x can also be calculated by rearranging Eq. (4) as
The equations here developed are equivalent to making a two-point Scatchard plot. This shows why two studies are the irreducible minimum needed for calculating Kd and Bmax. If more than two studies, performed at different values of L, are to be ana lyzed, then a conventional least-squares straight
[B(T)/I1L can be used for calcu lating the kinetic constants. The in vivo situation is complicated by metabolic transformation of tracer and of cold ligand. It will be assumed in the following that the metabolism takes place outside the brain and that labelled me tabolites cannot penetrate the blood:brain barrier. It is also assumed that the plasma concentrations measured are solely those of the genuine, lipophilic receptor ligands. Another complication of the in vivo situation arises from nonspecific binding of the ligands to proteins and lipids in brain and in plasma. Assuming that this binding is nonsaturable (or else it would have the nature of specific binding to re ceptor sites), the following ratios are constant: (10) fT and fL are the ratios of the concentrations in plasma ultrafiltrate divided by that of whole plasma for the two ligands, respectively. A is the concen tration ratio of nonreceptor-bound tracer (free and dissolved in proteins and lipids) in brain and in whole plasma, i.e., A is the nonspecific volume of distribution of the tracer.
Conceptually, A equals the partition coefficient defined by Kety (1951) for the lipophilic, freely dif fusible, inert (i.e., nonreceptor-binding and non me tabolized) tracers such as H2, N20, 133 Xe, or 1 4 C_ iodo-antipyrine. The fair degree of constancy of the gross physicochemical composition of brain and plasma, i.e., the percentage content of water, pro teins, and lipids determining the solubility, implies that the solubility ratio, A, is also practically con stant, i.e., constant in a given subject studied in different situations and also from one subject to the next. The constancy of A is the basis for using inert, freely diffusible tracers for measuring blood flow in various organs and tissues. The nitrous oxide method for measuring cerebral blood flow (CBF) devised by Kety and Schmidt (1945) is the proto type of these methods, and it still holds its position as the most reliable method for measuring the av erage CBF in man.
The same constancy, or near constancy, can be assumed a priori to hold for the A of lipophilic mol ecules that can penetrate the blood:brain barrier and bind to neuroreceptors in vivo. Moreover, since brain tissue and plasma are similar with re spect to gross physicochemical composition, it fol lows that A as a first approximation can be assumed close to unity (to lie between 0.5 and 2.0?) for all ligands. This prediction is based on the known val ues of A for the inert tracers listed above.
The total volume of distribution of the tracer in the brain, V, is defined as the equilibrium brain! plasma concentration ratio (11) This concentration ratio is not constant, but a func tion of the cold ligand's concentration, L. VeL) has the nature of a virtual or "imaginary" volume: It is, according to the definition, the volume of plasma that contains the same amount of tracer as one unit volume of brain tissue at equilibrium between the two phases. VeL) is the sum of the specific and nonspecific volumes of distribution, i.e.,
Inserting C p (T) = TifT and rearranging gives
This allows rewriting Eqs. (5), (6), and (7) so as to get the operational equations:
where use is made of IT = IL when rewriting Eq. (7) to obtain Eq. (16) because, in this case tracer and cold ligand are chemically the same. It follows from Eq. (3) that at very high concen tration of the cold ligand, the ratio B(T)/T and hence also B(T)/Cp(T) will become vanishingly small. Thus, rearranging Eq. (12) for very high concentra tions of the cold ligand yields:
This shows that A can be determined as the Cb/Cp ratio for very high values of L.
DETERMINATION OF V BY NONCOMPARTMENTAL ANALYSIS
Constant infusion of the radioactive tracer until equilibrium is reached is the most obvious way of determining the equilibrium brain/plasma concen tration ratio V. This was used by Kawai et al. (1991) for their receptor studies in animals. The alternative to the constant tracer infusion is the tracer bolus injection approach which is presented in this paper for the first time. In this case, the entire time course of the brain and plasma curves is observed. Hence the method, although more cumbersome, makes more effective use of the injected tracer. Thus, this approach is particularly well suited for receptor studies in man using positron emission tomography (PET) or single photon emission tomography (SPECT). V is in this case calculated as the ratio of the areas under the brain and plasma curves. The relation between the two noncompartmental ap proaches is thus constant tracer infusion
This relation is a consequence of the stationarity and linearity of the tracer responses, because these two conditions permit one to derive the stimulus/ response theorem of Perl (1971) . This theorem states that the equilibrium ratio of any two param eters in a continuous tracer infusion experiment (one arbitrarily denoted stimulus, the other re sponse) equals the area ratio of the same two pa rameters in a bolus tracer injection study (Perl 1971, Lassen and Perl, 1979) . In order to extrapolate the Vol. 12, No.5, 1992 areas to infinity, the curves must be followed for so long that conventional monoexponential extrapola tion can be used. It should be noted that with both noncompart mental approaches Cp(oo) can be sampled from a peripheral vein: Arterial sampling is not necessary as Cp(oo) must be the same for artery and vein if the tracer is not metabolized in the tissue drained by the vein. As this is so, then f�Cp(t)dt must also be the same for artery and peripheral vein because of the stimUlus/response theorem.
It is even possible to avoid blood sampling alto gether if a receptor-free "reference" region exists in the brain. In this case, we can define a modified volume of distribution, i.e., V' = [Cb(T)/CrerCT)] at tracer equilibrium and the corresponding area ratio with tracer bolus injection. Eq. (11) shows that V = V' . Are f' so that Eq. (13) 
. This, inserted into the opera tional equations, results in simple expressions for calculating the kinetic constants.
DETERMINATION OF V BY COMPARTMENTAL ANALYSIS
Conventional compartmental analysis has been widely used to study the tracer kinetics in the steady state when no cold ligand is infused. As stated in the classic paper by Mintun et al. (1984) , this approach does not allow one to calculate Bmax and Kd separately, but rather only their ratio. The approach is thus equivalent to performing a Scatch ard plot with a single point, namely, L � 0, allowing one only to assess the Y-axis intercept [B(T)ll1o which equals Bma x /Kd (see also Eq. (4».
This study is apparently the first proposing to use compartmental analysis with two tracer studies per formed at two different steady-states in the same subject: without and with constant infusion of the cold ligand. In this way both YeO) and VeL) can be calculated, and hence Kd and Bmax are both ob tained in case T and L are chemically identical. The compartmental analysis can in principle be applied both to the constant tracer infusion experiment and to the bolus injection one. Only the bolus case will be discussed, however, as this is the situation that actually has been studied in the literature (but, as mentioned, only with a single steady-state study per subject). A basic difference compared to the non compartmental analysis is that the arterial plasma curve Ca.p(t) must be sampled.
Explicit solutions of two-(n = 2) and three-(n = 3) compartmental models have recently been pub-Ii shed by Koeppe et al. (1991) . Using their notation, the two solutions are
Cb(t) = X K I X [(k3 ' + k4 -X I )e-X tt 2 -1 + ( X 2 -k3 ' -k4)e-X2t] * C a,P (t) .......... (n = 3) (20) where X I 2 = {(k2 ' + k3 ' + k4)
For the definition of the kinetic constants K, and k2 " (n = 2), and K1, k2 ' , k 3 ' , and k4 (n = 3) the reader is referred to the paper of Koeppe et al. (1991) . The compartmental approach first solves for these ki netic constants and their ratios are then used to calculate the volumes of distribution as follows: (22) Integrating Eqs. (19) and (20) so as to obtain the total area under the brain gives the product of the V and the area under the plasma curve. This result, which could be predicted from Eq. (18), shows that we may regard the analysis merely as a way of cal culating the brain/plasma area ratio. In fitting the convolution [Eqs. (19) and (20)] to the experimental curve, its area is the fitting parameter. It does not matter, therefore, if the derived kinetic constants correspond to the physical parameters presumed. The models may be wrong and yet V is correctly obtained by Eqs. (21) and (22). Nor is it important whether one uses the three compartmental model: As long as a good fit is obtained with n = 2, there is no need to use n = 3.
This very operational mode of using compart mental analysis corresponds closely to noncompart mental analysis. The important difference lies in that explicit extrapolation is not used. The kinetic constants obtained allow extrapolation to infinity for any arterial curve one might presume. Thus a rule of extrapolation is implicit but not used.
In the three-compartment model, X. equals K,/k2'. With the reservations mentioned above as to the precise meaning of K, and k/ and taking into ac count the considerable variance expected for these parameters, it is most likely that this estimate of X. is not very accurate. Checking X. thus obtained with more direct determinations of this parameter should be made for a given specified receptor/ligand pair to confirm whether the three-compartment approach can be trusted for calculating not only V but also X..
DISCUSSION
The steady-state principle analyzed in this paper rests on elementary and well-known kinetic con cepts. It is surprising, therefore, that the basic idea of studying (at least) two different steady states, two different occupancies, in order to draw a line on the Scatchard plot, has not been used in the already voluminous literature on neuroreceptor quantita tion by PET or SPECT. It was recognized, as very clearly stated by Mintun et al. (1984) , that a single high specific activity tracer study would not suffice. But, the solution to this problem has been to violate the steady state by co-injecting the cold ligand as a bolus along with the tracer.
The nonsteady-state studies have first of all been analyzed by the pseudoequilibrium approach (Farde et aI., 1986; Pappata et aI., 1988) . This is based on assuming the existence of a reference re gion in the brain which is devoid of receptors and at the same time has the same nonspecific volume of distribution, X., as the receptor-containing region of interest (ROJ). It is further assumed that the refer ence region's concentration curve will equal the ROI's nonspecific concentration curve, and that a state of near-equilibrium exists in a given time in terval between bound and free in the ROI. All these assumptions are open to critique. A more sophisti cated approach, taking the non stationarity into ac count, has been presented by Blomquist et al. (1990) and applied to a limited number of experi mental studies. The most elaborate analysis of this type did not allow one to obtain Kd, only B m ax (Del forges et aI., 1991).
The continuous tracer-infusion, steady-state method of Kawai et al. (1991) This study represents the first and only study in which the steady-state principle has been presented clearly and implemented in precise detail. It con cerns the study of the B m ax and Kd of the opiate receptor in rats using an antagonist, cyclofoxy, as tracer and as cold ligand as well. A series of studies at different levels of specific activity was carried out using a Scatchard plot for determining the ki netic constant. This study contains many pertinent details. Notably, it shows how to shorten the time to reach equilibrium by using a priming bolus injec tion followed by constant infusion of the tracer the classic approach used in renal clearance studies.
The study makes use of a nonreceptor-binding ste reoisomer to determine A. It also presents an ap proach for finding Bmax from a single study and val idates this approach by the Scatchard analysis men tioned.
The continuous tracer infusion method is well suited for animal studies, as only one experimental point, the equilibrium one, must be sampled as con ventionally done by tissue sampling or autoradiog raphy ex vivo. For this purpose, the approach will undoubtedly constitute the standard for future work. It may also be applied to clinical studies. In this context, however, the waiting period (to reach tracer equilibrium) may create problems when short-lived radioisotopes are used with PET.
The bolus-tracer-injection, steady-state method
This new approach was designed by the author for clinical studies with PET or SPECT. It demands that a series of brain scans be taken so as to obtain the time-concentration curve for each region of in terest. Theoretically, its main difficulty lies in the necessity for extrapolation, a difficulty that paral lels the need for reaching true equilibrium with the constant infusion approach. However, in the latter method Kawai et al. (1991) chose to use a combined injection-infusion protocol to "speed up" the ar rival of infinity time (true equilibrium) and not to use extrapolation.
Instead of the conventional monoexponential ex trapolation one might also follow the approach Kety and Schmidt (1948) used in developing the nitrous oxide method for measuring CBF, viz., to end the area calculation at a fixed time, when most of the area (say 90% of the extrapolated value) had al ready been directly observed. With this approach one would have to accept some errors while at the same time avoiding the possibility of more serious errors caused by extrapolating low-count rate points on the downslope of the curves.
The compartmental analysis was proposed as an alternative means of avoiding the errors of extrap olation. Care was taken to point out that the ap proach implies, indirectly, a sort of extrapolation (an extrapolation one could make). But in this case the entire curve, and not just a few less well-defined downslope curvepoints, is used for fitting. In the present analysis, it was emphasized that compart mental analysis may be considered merely as an operational tool.
The nonspecific volume of distribution
The determination of A as V(oo) , the distribution volume at very high concentrations of the cold Vol. 12, No.5, 1992 ligand L, has already been mentioned. It should be stressed that L must truly be high, on the order of 100 times Bmax, for obtaining the correct, minimal VeL) value that can be taken as V(oo). Another ap proach consists in using YeO) or VeL) of a receptor free region assumed to have the same A as the re gion of interest. The method used by Kawai et al. (1991) of employing a non-receptor-binding stereo isomer is, in some cases, applicable. Here it is es sential, obviously, that the stereoisomer have pre cisely the same physical solubility as the ligand and truly zero receptor affinity.
Regardless of the approach used, it is important to obtain an accurate estimate of A because it must be subtracted from YeO) and VeL) to correct for non specific tracer uptake. Because A is close to unity, it is best, if YeO) and VeL) have a relatively high nu merical value, as is the case when Kd is low. This, on the other hand, means that the mean retention time, which is proportional to YeO) and V(L) , be comes long. Thus, 1 23 I-Iabelled tracers (t1 / 2 = 13 h) combined with SPECT offer advantages over l 1 C _ labelled tracers (11 / 2 = 20 min) used with PET.
Neuroreceptor studies in vivo as a pharmacological tool
Usually in vivo receptor studies are performed with tracer and cold ligand being chemically identi cal. In this special case, when Kd r = Kd L , the nec essary kinetic equations can be expressed in a sim pler way than the one used in this paper. All one must know to perform a classic Scatchard plot to obtain Kd and Bmax is two (or more) points of the type Eqs. (8) to (13) . This simple way of present ing the kinetic analysis was, however, not chosen because it was considered of interest first to analyze the general case, when Kd r is not necessarily equal to Kd L
• In this situation, the tracer cannot be con sidered to trace the cold ligand, but simply the available receptor sites. As was shown, all one can calculate is then D(L) and hence Kd L , not Bmax. The general case is of particular interest for phar macological studies. Suppose one wanted to study a drug that binds to several different neuroreceptors. How can Kd be calculated for each one of these receptors separately in vivo? One way to proceed would be to use a series of tracers, each of them binding exclusively to one of the receptors. In this way, one could, step by step, determine the drug ' s receptor-binding profile in animals or in man. The data obtained, the set of Kd values, would allow calculation of the receptor occupancies at any given plasma concentration. Pharmacological studies of this kind are currently undertaken by teams with which this author collaborates. It remains to be seen to what extent such studies will really add to the information gathered from much less costly in vitro studies.
CONCLUSION
The formal identity of the constant tracer infusion study and the tracer bolus injection study, ex pressed by the stimulus/response theorem of Perl (1971), deserves a general comment. This identity explains why neither the blood flow nor KJ, k2 ' ... kn (here reference is made to classic compartmental analysis) is of importance. In the bolus injection experiment, significant diffusion gradients exist be tween the different pools of tracer during the wash in. Yet they cancel out by the integration proce dure, as they are precisely counterbalanced by the reverse gradients during the wash-out. The steady state principle thus allows one to take into account any degree of heterogeneity of the nonspecific pools, free as well as bound. Receptor heterogene ity, i.e., differences in Kd, could in principle also be present without changing the model used. In this situation, however, a series of studies with different concentrations of cold ligand must be used.
The necessity for reaching equilibrium for the tracer, a true equilibrium in the case of tracer infu sion and an equivalent time-averaged equilibrium in the tracer bolus case, is an essential point. This demands in practice that the tracer be irreversibly cleared, i.e., eliminated elsewhere in the body, and that irreversible binding in the brain, or at least very prolonged binding, not take place. Therefore, trac ers with very high affinity, i.e., with a very low Kd value, cannot be used for receptor quantitation. Several studies have been published using tracers binding too firmly to be of value for receptor quan titation in terms of Kd and Bmax' The studies of 3 H-scopolamine by Frey et al. (1985) , of IIC_ methylspiperone by Wong et al. (1986a Wong et al. ( , 1986b , and of 18F-spiroperidol by Perlmutter et al. (1986) may serve to illustrate this point. With such tracers only k 3 ' the fractional rate of binding to the receptor, can be calculated and this only in case k 3 is not much greater than K I ' because then the rate of delivery, essentially blood flow, completely dominates the uptake. It can be concluded, therefore, that meth ods for in vivo measurement of Kd and Bmax must use tracers with so Iow a Kd, that unspecific binding is not too big a problem and yet not so very Iow a Kd that virtually irreversible binding invalidates the method. In this author's experience, tracers useful for quantitating the benzodiazepine receptor must have Kd values lying between 10 and 0.5 nmol per liter.
The final point to be made concerns the situation when an endogenous ligand E is present in signifi cant concentration E. In this case, the study using radioactive tracer alone will have a bound/free ratio equalling Bmax/(Kdh, where (Kd)T = (Kdh (1 + EI(Kd)E)' Because E might well change (decrease?) during infusion of cold ligand, such an experiment does not allow precise kinetic analysis. Of more interest would be to perform a tracer study during pharmacological blockade of the release of E, as the pair of studies without and with blockade would allow one to calculate O(E), the endogenous occu pancy, and infusing a cold ligand during such a blockade would allow a complete kinetic analysis yielding Kd as well as Bmax.
